ZOAR Zoar Limited
Zoar Limited, a pharmaceutical company, focuses on the development and manufacture of active pharmaceutical ingredients. It also provides contract development and manufacturing services to pharmaceutical and biotechnology companies worldwide. The company was founded in 2012 and is headquartered in Grand Cayman, the Cayman Islands.…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
About Zoar (NYSEAMERICAN: ZOAR)
›
Zoar (NYSEAMERICAN: ZOAR) is listed on NYSE American, where its shares trade in USD. It belongs to the Drug Manufacturers - General industry, part of the Healthcare sector.
The shares were at 4.360 USD on 19 November 2026. Its 52-week range is 3.745 USD to 6.720 USD: the price is 35.1% below the high and 16.4% above the low.
Its market capitalisation is 784.80M USD.
Zoar reports return on equity of 18.7% and an operating margin of 0.0%.
Its Piotroski F-score is 7 out of 9, a strong reading of its financial health.